Advances in mobilization for the optimization of autologous stem cell transplantation

CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy

(2009) A. K. Azab et al.   BLOOD

Impact of Mobilization and Remobilization Strategies on Achieving Sufficient Stem Cell Yields for Autologous Transplantation

(2008) Iskra Pusic et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction

(2008) S. M. Devine et al.   BLOOD

Cul4A is required for hematopoietic cell viability and its deficiency leads to apoptosis

(2008) D. L. Waning et al.   BLOOD

Acute myeloid leukemia in a healthy hematopoietic stem cell donor following past exposure to a short course of G-CSF

(2008) C C Hsia et al.   BONE MARROW TRANSPLANTATION

Bendamustine, but not fludarabine, exhibits a low stem cell toxicity in vitro

(2008) M. Schmidt-Hieber et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Compromised stem cell mobilization following induction therapy with lenalidomide in myeloma

(2008) H Paripati et al.   LEUKEMIA

CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers

(2008) J A Burger et al.   LEUKEMIA

Radioimmunotherapy-Based Conditioning Regimens for Stem Cell Transplantation

(2008) Michelle M. Zhang et al.   SEMINARS IN HEMATOLOGY

The role of pegfilgrastim in mobilization of hematopoietic stem cells

(2008) Frank Kroschinsky et al.   TRANSFUSION AND APHERESIS SCIENCE

Management strategies for poor peripheral blood stem cell mobilization

(2008) Rainer Moog   TRANSFUSION AND APHERESIS SCIENCE